158 related articles for article (PubMed ID: 23436712)
1. Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?
Chaabna K; Bray F; Wabinga HR; Chokunonga E; Borok M; Vanhems P; Forman D; Soerjomataram I
Int J Cancer; 2013 Sep; 133(5):1197-203. PubMed ID: 23436712
[TBL] [Abstract][Full Text] [Related]
2. Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations.
Chaabna K; Boniol M; de Vuyst H; Vanhems P; Antônio de Ávila Vitoria M; Curado MP
Eur J Cancer Prev; 2012 Jan; 21(1):1-9. PubMed ID: 21955799
[TBL] [Abstract][Full Text] [Related]
3. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.
Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW
Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145
[TBL] [Abstract][Full Text] [Related]
4. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
Bahl S; Theis B; Nishri D; Marrett LD
Cancer Causes Control; 2008 Dec; 19(10):1251-8. PubMed ID: 18618279
[TBL] [Abstract][Full Text] [Related]
5. Ranula: another HIV/AIDS associated oral lesion in Zimbabwe?
Chidzonga MM; Rusakaniko S
Oral Dis; 2004 Jul; 10(4):229-32. PubMed ID: 15196145
[TBL] [Abstract][Full Text] [Related]
6. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.
Chokunonga E; Borok MZ; Chirenje ZM; Nyakabau AM; Parkin DM
Int J Cancer; 2013 Aug; 133(3):721-9. PubMed ID: 23364833
[TBL] [Abstract][Full Text] [Related]
7. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
[TBL] [Abstract][Full Text] [Related]
8. Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda).
Stoeter O; Seraphin TP; Chitsike I; Chokunonga E; Kambugu JB; Wabinga H; Parkin DM; Kantelhardt EJ
Int J Cancer; 2021 Sep; 149(5):1002-1012. PubMed ID: 33945631
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
10. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
12. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand.
Sriplung H; Parkin DM
Cancer; 2004 Dec; 101(11):2660-6. PubMed ID: 15495138
[TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence of cancer in Kampala, Uganda 1991-2010.
Wabinga HR; Nambooze S; Amulen PM; Okello C; Mbus L; Parkin DM
Int J Cancer; 2014 Jul; 135(2):432-9. PubMed ID: 24615279
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995.
Chokunonga E; Levy LM; Bassett MT; Mauchaza BG; Thomas DB; Parkin DM
Int J Cancer; 2000 Jan; 85(1):54-9. PubMed ID: 10585583
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related cancers in Africa: maturation of the epidemic in Uganda.
Parkin DM; Wabinga H; Nambooze S; Wabwire-Mangen F
AIDS; 1999 Dec; 13(18):2563-70. PubMed ID: 10630526
[TBL] [Abstract][Full Text] [Related]
19. AIDS-related Kaposi's sarcoma in Brazil: trends and geopolitical distribution.
Saraceni V; Talhari CC; Pereira GF; Golub JE; Talhari S; Miranda AE
Int J Dermatol; 2013 Dec; 52(12):1525-9. PubMed ID: 24134514
[TBL] [Abstract][Full Text] [Related]
20. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
